Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Chemical Structure: Synthetic 39 amino acid triple agonist, Proprietary Complex peptidyl structure with C 20 fatty acid Alternative Names: LY3437943 CAS Number: Not applicable WHAT IS RETATRUTIDE Retatrutide, also known as LY-3437943, is an experimental medication developed by Eli Lilly that is being studied as a next-generation treatment for obesity, overweight, and related metabolic conditions such as type 2 diabetes
Surg Gynecol Obstet
& Pessin, J
The Phase 2 trial ran for 48 weeks with continuous dosing
US$ 29.08
US$ 21.63
US$ 27.39
